Pharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD Participants
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: This study assessed patterns of psychopharmacological treatment for bipolar disorder. METHOD: Intake treatment data were examined for the first 500 patients in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) study (1998 to 1999). Diagnoses were assessed by using the Structured Clinical Interview for DSM-IV mood modules. Data on treatments were obtained by interviewing patients during the initial psychiatric examination. RESULTS: Of the 500 participants, 73.6 percent had bipolar I disorder, 23.0 percent had bipolar II disorder, and 3.4 percent had bipolar disorder not otherwise specified. Upon examination, 63.4 percent were euthymic, 24.6 percent were depressed, and 12.0 percent were experiencing manic, hypomanic, or mixed states. Standard mood stabilizers (lithium, valproate, or carbamazepine) were the most commonly prescribed class of drugs that participants were taking at intake (71.9 percent). The next most common class of agents was antidepressants (40.6 percent), followed by novel anticonvulsants (31.8 percent), second-generation neuroleptics (27.2 percent), and benzodiazepines (25.0 percent). Eleven percent of patients were treated with standard mood stabilizer monotherapy. These prescribing patterns were further analyzed by subtype of illness and compared with patterns in other clinical and community settings. CONCLUSION: In a large, well-characterized cross-sectional analysis of prescription patterns in the U.S. psychiatric academic setting, patients with bipolar disorder were primarily treated with standard mood stabilizers, followed by moderate use of antidepressants, novel anticonvulsants, and second-generation neuroleptics. Results can be useful in understanding the current clinical standard of care, as well as in guiding research studies toward areas in which there is a relative absence of evidence to inform clinical practice. Studies of longitudinal prescribing patterns in bipolar disorder are also needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Maser, J., Solomon, D. A., Leon, A. C., Rice, J. A., & Keller, M. B. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.530 · Cited by 2,106
Screening for Bipolar Disorder in the Community
Hirschfeld, R. M. A., Calabrese, J. R., Weissman, M. M., Reed, M., Davies, M. A., Frye, M. A., Keck, P. E., Lewis, L., McElroy, S. L., McNulty, J. P., et al. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0111 · Cited by 674
Tohen, M., Calabrese, J. R., Sachs, G. S., Banov, M. D., Detke, H. C., Risser, R., Baker, R. W., Chou, J. C.-Y., & Bowden, C. L. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.247 · Cited by 317
Self-citationAltshuler, L., Suppes, T., Black, D., Nolen, W. A., Keck, P. E., Frye, M. A., McElroy, S., Kupka, R., Grunze, H., Walden, J., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.7.1252 · Cited by 287
Zanarini, M. C., Frankenburg, F. R., Hennen, J., & Silk, K. R. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0105 · Cited by 285
Ohayon, M. M., & Lader, M. H. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0912 · Cited by 271
Berk, M., & Dodd, S. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2004.00152.x · Cited by 134
WEHR, T. A., & GOODWIN, F. K. (1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.7.906-a · Cited by 60
Research works printed but not linked: 24
- 10.1097/00004714-199604001-00005 · DOI
- 10.1176/appi.ajp.159.6.1005 · DOI · Paper page
- Ghaemi SN, 2001, 3, 154
- Zarate, 1995, Journal of Clinical Psychiatry, 56, 260
- Ghaemi SN, 2002, Canadian Journal of Psychiatry, 47, 125, 10.1177/070674370204700202 · DOI · Paper page
- 10.3109/10673229409017110 · DOI
- 10.1034/j.1399-5618.2002.01223.x · DOI
- 10.1034/j.1399-5618.2001.30401.x · DOI
- 10.1034/j.1399-5618.2000.020205.x · DOI
- 10.1034/j.1399-5618.2001.030106.x · DOI
- 10.1034/j.1399-5618.2002.01216.x · DOI
- 10.1016/S0006-3223(03)00165-3 · DOI · Paper page
- 10.1016/S0165-0327(01)00432-3 · DOI · Paper page
- 10.1016/S0165-0327(00)00279-2 · DOI
- 10.1176/appi.ajp.161.9.1537 · DOI · Paper page
- 10.4088/JCP.v62n07a12 · DOI
- 10.1111/j.1600-0447.2004.00410.x · DOI
- 10.1111/j.1600-0047.2004.00295.x · DOI
- 10.1034/j.1600-0447.2003.00126.x · DOI
- 10.1192/bjp.184.4.337 · DOI · Paper page
- 10.1176/appi.ajp.162.7.1281 · DOI · Paper page
- 10.1176/appi.ajp.160.7.1263 · DOI · Paper page
- Marcus R, 2004, New York
- Ghaemi SN, 2004, Journal of Clinical Psychiatry, 65, 16
Cited by
Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
Sachs, G. S., Nierenberg, A. A., Calabrese, J. R., Marangell, L. B., Wisniewski, S. R., Gyulai, L., Friedman, E. S., Bowden, C. L., Fossey, M. D., Ostacher, M. J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064135 · Cited by 937
Self-citationGrunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., & on behalf of the WFSBP Task Force on Treatment Guidelines for Bipolar Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.770551 · Cited by 421
Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., & WFSBP Task Force On Treatment Guidelines For Bipolar Disorders (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622970903555881 · Cited by 399
“…bipolar depression including inositol (Evins et al. 2006; Nierenberg et al. 2006) (CE D), zonisamide (Baldassano et al. 2004; McElroy et al. 2005; Ghaemi et al. 2006b; Wilson and Findling 2007)(CE C1, RG 4), topiramate (McIntyre et al. 2002) (CE C1, RG 4), omega-3 fatty acids (Frangou et al.…”
MethodGrunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., WFSBP Task Force on Treatment Guide, Grunze, H., Vieta, E., et al. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970902823202 · Cited by 346
Ng, T. H., Chung, K.-F., Ho, F. Y.-Y., Yeung, W.-F., Yung, K.-P., & Lam, T.-H. (2015) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2014.06.006 · Cited by 283
Metadata
- Authors
- Ghaemi, S. N., Hsu, D. J., Thase, M. E., Wisniewski, S. R., Nierenberg, A. A., Miyahara, S., & Sachs, G.
- Venue
- Psychiatric Services
- Published
- 2006-05-01
- Volume
- 57
- Issue
- 5
- Pages
- 660-665
- ISSN
- 0022-1597 (ISSN-L)
- 1075-2730
- OpenAlex
- W2128861864
- Cited by
- 121
- References
- 8
- FWCI
- 6.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.